UB officials spent two days last week meeting with representatives of King Saud University in Saudi Arabia to discuss potential research collaborations engendered by groundbreaking Saudi research conducted in collaboration with UB researchers.
The research, published in the August issue of Neoplasia, describes, in a mouse model, a novel vaccine immunotherapy approach that may be able to decrease the tumor burden in cancer patients by blocking cancer metastasis.
Adel Almogren, professor in the Department of Pathology and Immunology in the College of Medicine at King Saud University, is one of the principal authors on the paper. Kate Rittenhouse-Olson, professor of biotechnical and clinical laboratory sciences in the UB School of Medicine and Biomedical Sciences, is senior author.
Almogren conducted research at UB as a master’s student under Rittenhouse-Olson’s direction, and has been in contact as a collaborator since leaving Buffalo.